跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
APREMILAST KRKA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
APREMILAST KRKA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 15, 2025
Approval ID
ab91da842af123b3
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
ab91da842af123b3
Drug Cima Aemps Name
APREMILAST KRKA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
90339
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2025-09-15
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Krka D.D. Novo Mesto
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 15, 2025
Approval ID
ab91da842af123b3
Type
Standard
Back to CIMA-AEMPS Approvals
APREMILAST KRKA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details